期刊文献+

来那度胺可抑制单核细胞向M2型巨噬细胞分化及相关细胞因子的分泌 被引量:4

Lenalidomide significantly inhibits the differentiation of monocytes to M2 polarized macrophages and down-regulates secretion of associated cytokines
下载PDF
导出
摘要 目的探索来那度胺在肿瘤微环境中对于单核细胞向M2型巨噬细胞分化及IL-10、VEGF和TGF-β1水平的影响。方法密度梯度离心法分离初治淋巴瘤患者及健康志愿者外周血单个核细胞(PBMCs)。用Transwell24孔板共培养PBMCs与淋巴瘤细胞系HUT-78,并于共培养体系中加入来那度胺。流式细胞术分析肿瘤相关巨噬细胞(TAM)特征性表型CD68和CD163的表达,ELISA法检测共培养体系细胞因子IL-10、VEGF和TGF-β1的含量。结果在PBMCs与HUT-78构成的体外共培养体系中加入来那度胺后,CD68+、CD163+、CD68+CD163+细胞及CD68+CD163+在CD68+细胞中所占比例均有显著的下降(P<0.05)。加入来那度胺后患者组CD68+CD163+/CD68+下降程度明显高于健康志愿者(P<0.05)。加入来那度胺的患者共培养组相对于未加来那度胺的共培养组IL-10和VEGF水平均有显著下降(P<0.01,P<0.05)。结论来那度胺在PBMCs与淋巴瘤细胞构建的体外共培养体系中能够有效抑制单核细胞向M2型TAM的分化,且能够抑制患者组共培养体系中IL-10、VEGF分泌。 Objective To explore the impact of anti-cancer drug Lenalidomide on the differentiation of monocytes to M2 polarized macrophages and the secretion of IL-10,VEGF and TGF-β1.Methods The peripheral blood mononuclear cells (PBMCs) were isolated by Ficoll-Hypaque density gradient centrifugation from peripheral blood of both lymphoma patients and healthy controls.Then PBMCs were co-cultured with HUT-78 lymphoma cells in Transwell 24-well plates.Anti-cancer drug Lenalidomide was added into the co-culture system.Expressions of the markers of TAMs (CD68 and CD163) were tested by flow cytometry.IL-10,VEGF and TGF-β1 level in the co-culture system were detected by ELISA.Results Treatment with Lenalidomide significantly decreased the proportion of CD68+,CD163 +,CD68 + CD163 + cells and the proportion of CD68 + CD163 + / CD68 + cells(P < 0.05).The degree of decline of CD68 + CD163 +/CD68 + cells was more significant in patients than that in healthy controls(P < 0.05).The reatment with Lenalidomide significantly decreased the IL-10 and VEGF level in the co-culture system (P < 0.01,P < 0.05).Conclusions Lenalidomide significantly inhibits the differentiation of monocytes to M2 polarized macrophages and down-regulate the secretion of IL-10 and VEGF in the co-culture system in patient group.
出处 《基础医学与临床》 CSCD 2015年第6期786-791,共6页 Basic and Clinical Medicine
基金 北京市自然科学基金(7122140)
关键词 来那度胺 淋巴瘤 肿瘤相关巨噬细胞 lenalidomide lymphoma tumor-associated macrophage
  • 相关文献

参考文献11

  • 1Lin EY, Nguyen AV, Russell RG, et al. Colony-stimula- ting factor 1 promotes progression of mammary tumors to malignancy[J]. Exp Med, 2001, 193:727-740.
  • 2Biswas SK, Sica A, Lewis CE. Plasticity of macrophage function during tumor progression: Regulation by distinct molecular mechanisms [ J]. J Immunol, 2008, 180: 2011-2017.
  • 3Dominguez-Soto A, Sierra-Filardi E, Puig-Kroger A, et al. Dendritic cellspecific ICAM-3-grabbing nonintegrin expres-sion on M2-polarized and tumor-associated macrophages is macrophage-CSF dependent and enhanced by tumor-derived IL-6 and IL-IO[J]. J lmmunol, 2011,186:2192-2200.
  • 4Mantovani A, Sozzani S, Locati M, et al. Macrophage po- larization: Tumor-associated maerophages as a paradigm for polarized M2 mononuclear phagocytes [ J ]. Trends Immu- nol, 2002, 23: 549-555.
  • 5Buechler C, Ritter M, Orso E, et al. Regulation of scaven- ger receptor CD163 expression in human monocytes and macrophages by pro- and antiinfiammatory stimuli [ J ]. J Leukoc Biol, 2000, 67: 97-103.
  • 6廖红,蔡绮纯,王潇潇,蔡清清,林旭滨,林桐榆,夏忠军,李志铭,姜文奇,黄慧强.CD68阳性淋巴瘤相关巨噬细胞在滤泡性淋巴瘤间质中的密度及其临床意义的研究[J].中国肿瘤临床,2011,38(18):1081-1084. 被引量:3
  • 7Steidl C, Gascoyne RD, Farinha P, et al. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma [J]. N Engl J Med, 2010, 362:875-885.
  • 8Zhang W, Wang L, Zhou D, et al. Expression of tumor-as- sociated macrophages and vascular endothelial growth factor correlates with poor prognosis of peripheral T-cell lympho- ma, not otherwise specified [ J ]. Leuk Lymphoma, 2011, 52:46-52.
  • 9魏冲,王昊天,姜志超,张薇,曹欣欣,李天骄,汪玄,周道斌.肿瘤相关巨噬细胞与HUT-78淋巴瘤细胞相互作用的实验研究[J].中国实验血液学杂志,2014,22(4):988-994. 被引量:1
  • 10Verhelle D, Corral LG, Wong K, et al. Lenalidomide and CC-4047 inhibit the proliferation of malignant B cells while expanding normal CD34 + progenitor cells [ J ]. Cancer Res, 2007, 67: 746-755.

二级参考文献33

  • 1肖畅,苏祖兰,吴秋良,郜红艺,方建晨,夏忠军,管忠震.根据WHO新分类对493例非霍奇金淋巴瘤的临床病理分析[J].中华病理学杂志,2005,34(1):22-27. 被引量:54
  • 2Fisher RI,LeBlanc M,Press OW,et al.New treatment options have changed the survival of patients with follicular lymphoma[J].J Clin Oncol,2005,23(33):8447-8452.
  • 3Liu Q,Fayad L,Cabanillas F,et al.Improvement of overall and failure-free survival in stage IV follicular lymphoma:25 years of treatment experience at The University of Texas M.D.Anderson Cancer Center[J].J Clin Oncol,2006,24(10):1582-1589.
  • 4Shipp M,Harrington D,Anderson J,et al.A predictive model for aggressive lymphoma:the international NHL prognostic factors project[J].N Engl J Med,1993,329(14):987-994.
  • 5Solal-Ce!aligny P,Roy P,Colombat P,et al.Follicular lymphoma international prognostic index[J].Blood,2004,104(5):1258-1265.
  • 6Chen JJ,Lin YC,Yao PL,et a1.Tumor-ssociated macrophages:the double-edged sword in cancer progression[J].J Clin Oncol,2005,23(5):953-964.
  • 7Bingle L,Brown NJ,Lewis CE.The role of tumor-associated macrophages in tumor progression:implications for new anticancer therapies[J].J Pathol,2002,196(3):254-265.
  • 8Sica A,Larghi P,Mancino A,et al.Macrophage polarization in tumour progression[J].Semin Cancer Biol,2008,18(5):349-355.
  • 9Solinas G,Germano G,Mantovani A,et al.Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation[J].J Leukoc Biol,2009,86(5):1065-1073.
  • 10Mantovani A,Sica A.Macrophages,innate immunity and cancer:balance,tolerance,and diversity[J].Curr Opin Immunol,2010,22(2):231-237.

共引文献2

同被引文献12

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部